Stem cells for bronchopulmonary dysplasia in preterm infants: A randomized controlled phase II trial

Abstract We previously demonstrated the safety and feasibility of mesenchymal stem cell (MSC) transplantation for bronchopulmonary dysplasia (BPD) in preterm infants in a phase I clinical trial. We thus investigated the therapeutic efficacy of MSCs for BPD in premature infants. A phase II double‐bli...

ver descrição completa

Detalhes bibliográficos

Principais autores:	So Yoon Ahn, Yun Sil Chang, Myung Hee Lee, Se In Sung, Byong Sop Lee, Ki Soo Kim, Ai‐Rhan Kim, Won Soon Park
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Oxford University Press 2021-08-01
coleção:	Stem Cells Translational Medicine
Assuntos:	bronchopulmonary dysplasia cell transplantation mesenchymal stem cells premature infants
Acesso em linha:	https://doi.org/10.1002/sctm.20-0330
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!